Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

OBJECTIVE: Patients with short bowel syndrome (SBS) and colon in continuity have better adaptation potential compared with patients with jejunostomy. Adaptation may involve enhanced postprandial secretion of the enteroendocrine hormones glucagon-like peptide (GLP)-1 and GLP-2 which are normally degr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Gastroenterol
Autors principals: Naimi, Rahim Mohammad, Hvistendahl, Mark Krogh, Thomassen, Lise Margrete, Johnsen, Hanna, Christiansen, Charlotte Bayer, Holst, Jens Juul, Hartmann, Bolette, Jeppesen, Palle Bekker
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Intestinal Failure
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117993/
https://ncbi.nlm.nih.gov/pubmed/33975891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2021-000604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars